drugset / Trial / NCT00215397

Study in Patients With Asthma

NCT00215397

Phase 2 Completed 16 enrolled Dey
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.

Timeline

Start
Primary completion
2003-02
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified

Indications